78 related articles for article (PubMed ID: 12705885)
41. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine.
Okazaki T; Maeda A; Nishimura H; Kurosaki T; Honjo T
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13866-71. PubMed ID: 11698646
[TBL] [Abstract][Full Text] [Related]
42. Regulation of B cell signal transduction by SH2-containing protein-tyrosine phosphatases.
Siminovitch KA; Neel BG
Semin Immunol; 1998 Aug; 10(4):329-47. PubMed ID: 9695189
[TBL] [Abstract][Full Text] [Related]
43. Leptin receptor activation of SH2 domain containing protein tyrosine phosphatase 2 modulates Ob receptor signal transduction.
Li C; Friedman JM
Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9677-82. PubMed ID: 10449753
[TBL] [Abstract][Full Text] [Related]
44. Critical role of Src and SHP-2 in sst2 somatostatin receptor-mediated activation of SHP-1 and inhibition of cell proliferation.
Ferjoux G; Lopez F; Esteve JP; Ferrand A; Vivier E; Vely F; Saint-Laurent N; Pradayrol L; Buscail L; Susini C
Mol Biol Cell; 2003 Sep; 14(9):3911-28. PubMed ID: 12972574
[TBL] [Abstract][Full Text] [Related]
45. Tyrosine phosphatase SHP-2 binding to CTLA-4: absence of direct YVKM/YFIP motif recognition.
Schneider H; Rudd CE
Biochem Biophys Res Commun; 2000 Mar; 269(1):279-83. PubMed ID: 10694513
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases.
Le Dréan E; Vély F; Olcese L; Cambiaggi A; Guia S; Krystal G; Gervois N; Moretta A; Jotereau F; Vivier E
Eur J Immunol; 1998 Jan; 28(1):264-76. PubMed ID: 9485206
[TBL] [Abstract][Full Text] [Related]
47. Involvement of the SHP-1 tyrosine phosphatase in regulating B lymphocyte antigen receptor signaling, proliferation and transformation.
Siminovitch KA; Lamhonwah AM; Somani AK; Cardiff R; Mills GB
Curr Top Microbiol Immunol; 1999; 246():291-7; discussion 298. PubMed ID: 10396068
[No Abstract] [Full Text] [Related]
48. Impaired natural killing of MHC class I-deficient targets by NK cells expressing a catalytically inactive form of SHP-1.
Lowin-Kropf B; Kunz B; Beermann F; Held W
J Immunol; 2000 Aug; 165(3):1314-21. PubMed ID: 10903732
[TBL] [Abstract][Full Text] [Related]
49. Receptor activator of NF-kappa B ligand stimulates recruitment of SHP-1 to the complex containing TNFR-associated factor 6 that regulates osteoclastogenesis.
Zhang Z; Jimi E; Bothwell AL
J Immunol; 2003 Oct; 171(7):3620-6. PubMed ID: 14500659
[TBL] [Abstract][Full Text] [Related]
50. Cytoskeletal remodeling in vascular smooth muscle cells in response to angiotensin II-induced activation of the SHP-2 tyrosine phosphatase.
Fernstrom K; Farmer P; Ali MS
J Cell Physiol; 2005 Dec; 205(3):402-13. PubMed ID: 16021628
[TBL] [Abstract][Full Text] [Related]
51. Antigen receptor-triggered apoptosis in immature B cell lines is associated with the binding of a 44-kDa phosphoprotein to the PTP1C tyrosine phosphatase.
Wu Y; Pani G; Siminovitch K; Hozumi N
Eur J Immunol; 1995 Aug; 25(8):2279-84. PubMed ID: 7664792
[TBL] [Abstract][Full Text] [Related]
52. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
[TBL] [Abstract][Full Text] [Related]
53. Cloning of two new splice variants of Siglec-10 and mapping of the interaction between Siglec-10 and SHP-1.
Kitzig F; Martinez-Barriocanal A; López-Botet M; Sayós J
Biochem Biophys Res Commun; 2002 Aug; 296(2):355-62. PubMed ID: 12163025
[TBL] [Abstract][Full Text] [Related]
54. Membrane immunoglobulin-associated molecules on channel catfish B lymphocytes.
Rycyzyn MA; Wilson MR; Warr GW; Clem LW; Miller NW
Dev Comp Immunol; 1996; 20(5):341-51. PubMed ID: 9016388
[TBL] [Abstract][Full Text] [Related]
55. A mimotope attached to an ITIM-SHP-1 interaction inhibitory peptide boosts immune response and efficacy.
Roy K; Roy S; Roy S
RSC Med Chem; 2021 Jun; 12(6):994-999. PubMed ID: 34223164
[TBL] [Abstract][Full Text] [Related]
56. Putting the brakes on phagocytosis: "don't-eat-me" signaling in physiology and disease.
Kelley SM; Ravichandran KS
EMBO Rep; 2021 Jun; 22(6):e52564. PubMed ID: 34041845
[TBL] [Abstract][Full Text] [Related]
57. CD22: A Regulator of Innate and Adaptive B Cell Responses and Autoimmunity.
Clark EA; Giltiay NV
Front Immunol; 2018; 9():2235. PubMed ID: 30323814
[TBL] [Abstract][Full Text] [Related]
58. Cell rigidity and shape override CD47's "self"-signaling in phagocytosis by hyperactivating myosin-II.
Sosale NG; Rouhiparkouhi T; Bradshaw AM; Dimova R; Lipowsky R; Discher DE
Blood; 2015 Jan; 125(3):542-52. PubMed ID: 25411427
[TBL] [Abstract][Full Text] [Related]
59. Myosin-II inhibition and soft 2D matrix maximize multinucleation and cellular projections typical of platelet-producing megakaryocytes.
Shin JW; Swift J; Spinler KR; Discher DE
Proc Natl Acad Sci U S A; 2011 Jul; 108(28):11458-63. PubMed ID: 21709232
[TBL] [Abstract][Full Text] [Related]
60. Negative signaling by inhibitory receptors: the NK cell paradigm.
Long EO
Immunol Rev; 2008 Aug; 224():70-84. PubMed ID: 18759921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
